Company news

Absci Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 27, 2024

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 13, 2024

Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024

April 15, 2024

Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference

March 27, 2024

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

March 20, 2024

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

February 29, 2024

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

February 20, 2024

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

January 9, 2024

Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference

January 7, 2024

Absci to Participate in the 26th Annual Needham Growth Conference

January 2, 2024

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

December 19, 2023

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

December 3, 2023

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

November 14, 2023

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

November 13, 2023

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

November 13, 2023

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

September 20, 2023

Absci to Host R&D Day on October 4, 2023

September 5, 2023

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

August 13, 2023

Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer

August 13, 2023

Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development

August 9, 2023

Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023

July 31, 2023

Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference

July 25, 2023

Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit

June 14, 2023

Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips

June 5, 2023

Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results

May 14, 2023

University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

May 10, 2023

Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference

April 5, 2023

Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

April 3, 2023

Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

March 29, 2023

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

March 22, 2023

Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

March 6, 2023

Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland

February 27, 2023

Absci to Participate in the 43rd Annual Cowen Health Care Conference

February 20, 2023

St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies

February 8, 2023

Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation

February 7, 2023

Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI

January 9, 2023

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

January 7, 2023

Absci to Participate in the Berenberg Discover AI Seminar

November 22, 2022

Absci to Participate in the Piper Sandler Healthcare Conference

November 16, 2022

Absci Reports Third Quarter 2022 Financial Results

November 8, 2022

Absci Welcomes Meta Senior Executive to Board of Directors

November 1, 2022

Absci to Participate in the Stifel Healthcare Conference

November 1, 2022

Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference

October 25, 2022

Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer

October 3, 2022

Absci to Participate in the Morgan Stanley Global Healthcare Conference

August 31, 2022

Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase

August 23, 2022

Absci Reports Second Quarter 2022 Financial Results and Business Update

August 10, 2022

Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference

July 31, 2022

Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event

July 20, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 11 calls. Every call is listed under its year.

Decks

The 5 newest of 15 decks. Every deck is listed under its year.